All In MedTech

Device Trial Radar · NCT04963179

PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.

Last checked: Nov 20, 2026Latest source record: Mar 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

160

Actual

Start

Nov 29, 2021

Primary completion

Nov 11, 2023

Study completion Dec 2026

Sponsor

Lead sponsor
WomedNot on our public-company list
Sponsor type
Industry
First posted
Jul 15, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Prevention
FDA-regulated device
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

PREG2 is a randomized controlled trial that aims to evaluate efficacy in preventing intrauterine adhesion recurrence after hysteroscopic adhesiolysis of a novel intrauterine barrier film named Womed Leaf

Conditions

  • Asherman Syndrome
  • Intrauterine Adhesion

Interventions

  • Womed LeafDevice

    Womed Leaf™ device is composed of a uterine anti-adhesion film pre-loaded inside a flexible inserter. Womed Leaf™ is inserted in the uterine cavity by the gynecologist surgeon as a film folded into a 5 mm diameter flexible inserter. Once released, the film will unfold and swell into the uterine cavity to keep uterus walls separated. It is degraded and discharged naturally through the cervix and vagina.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy - IUA SeverityTime frame: At second look hysteroscopy between 4 and 8 weeks
  2. Safety - Adverse EventsTime frame: At second look hysteroscopy between 4 and 8 weeks

Locations

15 sites in 7 countries. Site status is shown where the registry gives one.

  • Gent UZ

    Ghent, Belgium

  • Guangdong Maternal and Child Health Hospital

    Guangzhou, China

  • Women's Hospital School Of Medicine Zhejiang University

    Hangzhou, China

12 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.